Lovisa Dahl Nelson, IP and Regulatory Manager/Member of the Swedish Bar Association

+46 10 690 04 07 +46 72 550 80 75 lovisa.nelson@setterwalls.se

Practice areas:

Intellectual property, marketing and media law

Industries:

Life Sciences

Office:

Malmo

Assistant:

Asia Vidovic

Visit Linkedin profile Download vCard

Profile

I work mainly with intellectual property law issues with a particular focus on trademark law and marketing law and with regulatory issues within Life Sciences.

I lead the day-to-day work of the trademark department in Malmö, which includes advice on corporate protection and commercialization of intellectual and other property. I am specialized in Life Sciences, i.a. in the pharmaceutical, medtech, and food area, and work in this area with regulatory issues, market access and marketing. I regularly assist companies in drawing up and reviewing contracts, primarily within my specialist areas and with intellectual property rights strategies and disputes.

Språk: English, Swedish, Swedish

Karriär

2011-2013

Hässleholm District Court, law clerk

2011-

Setterwalls

2011

Lund University, LL.M.

2010

Swedish Embassy in Canberra, internship

2008-2009

University of Edinburgh, School of Law

Rekommendationer

Chambers Europe

Who’s Who Legal

World Trademark Review

“Lovisa Dahl Nelson has broad and deep knowledge of intellectual property law and marketing law, together with a comprehensive industry experience and curiosity, she is able to provide practical advice on challenges and recommend business strategies.”

Legal 500
“Lovisa Dahl Nelson is a great IP lawyer.”

Legal 500
“Lovisa Dahl Nelson has, through long-time support to our business, distinguished herself for her business understanding, wide knowledge in the life sciences industry and solution-oriented, value-creating, way of work.”

Legal 500
“With strategic foresight and a brilliant grasp on the business objectives of her client, she effectively handles cross border IP strategies”

World Trademark Review
“Portfolio management ace Lovisa Dahl Nelson is always spot on”

World Trademark Review
“Lovisa is vital in helping brands become global powerhouses and combines a solid business understanding with relevant legal insight to provide thought-out advice that clients greatly benefit from”

WTR 1000
“Lovisa tilises her vast cross-border experience to provide clients with transparent, precise and practical advice.”

World Trademark Review
“An invaluable, dedicated professional with a strong insight into trademark law. She adeptly handles matters across the Swedish, Danish, and Norwegian markets and pro-vides commercially sound advice, thinking quickly on her feet.”

World Trademark Review
“IP and regulatory manager Dahl Nelson deftly navigates the fast-moving consumer goods and life sciences sectors, where she acquits herself with distinction across all facets of the practice.”

World Trademark Review

Case

Setterwalls has advised EQL Pharma in connection with listing on Nasdaq Stockholm

Setterwalls has advised TrusTrace in connection with a financing of USD 24 million

Setterwalls has advised SynAct Pharma AB in connection with listing on Nasdaq Stockholm

Setterwalls has assisted the Fristads Kansas Group in the sale of Fristads, Kansas and Leijona to Hultafors Group AB

Setterwalls has advised IRRAS AB in connection with rights issue of approximately SEK 217 million and listing on Nasdaq Stockholm main market

Setterwalls has assisted Ascelia Pharma in this year’s first listing at Nasdaq Stockholm

Setterwalls advises Better Collective in connection with listing on Nasdaq Stockholm

Setterwalls assists BONESUPPORT in connection with listing on Nasdaq Stockholm

Setterwalls advises Svedbergs in connection with an acquisition

Setterwalls assists Alligator Bioscience AB in connection with listing on Nasdaq Stockholm

Setterwalls advisor in revocation of pharma patent

Lovisa Dahl Nelson

Profile

Karriär

2011-2013

2011-

2011

2010

2008-2009

Rekommendationer

Case

Setterwalls has advised EQL Pharma in connection with listing on Nasdaq Stockholm

Setterwalls has advised TrusTrace in connection with a financing of USD 24 million

Setterwalls has advised SynAct Pharma AB in connection with listing on Nasdaq Stockholm

Setterwalls has assisted the Fristads Kansas Group in the sale of Fristads, Kansas and Leijona to Hultafors Group AB

Setterwalls has advised IRRAS AB in connection with rights issue of approximately SEK 217 million and listing on Nasdaq Stockholm main market

Setterwalls has assisted Ascelia Pharma in this year’s first listing at Nasdaq Stockholm

Setterwalls advises Better Collective in connection with listing on Nasdaq Stockholm

Setterwalls assists BONESUPPORT in connection with listing on Nasdaq Stockholm

Setterwalls advises Svedbergs in connection with an acquisition

Setterwalls assists Alligator Bioscience AB in connection with listing on Nasdaq Stockholm

Setterwalls advisor in revocation of pharma patent

Setterwalls assisted KLS Ugglarps in the acquisition of the majority shares in Dalsjöfors Kött

Setterwalls assists Bergendahls in the sale of commercial property in Fjälkinge, north of Kristianstad

Artiklar

Setterwalls Life Sciences Report May 2026

Regulatory changes in EU Cosmetics Law: Regulation (EU) 2026/78

Further reading on the new pharmaceutical inquiry

The Swedish Government is appointing a new medical products inquiry

Setterwalls Receives Gold Ranking in World Trademark Review

Setterwalls Life Sciences Report November 2025

Two Judgments on Sales of Alcoholic Beverages in Sweden on Producers’ Sites – Opening Hours Are Not Required to Match Those of Systembolaget

Proposal for a new Swedish product liability act – what does it mean?

Updates in the ethical rules – how are pharmaceutical companies affected?

Withdrawal of the proposed Green Claims Directive by the European Commission

Setterwalls Life Sciences Report May 2025

Important decision on the distinction between marketing and non-commercial information in relation to medicinal products

Strengthening EU’s medicine supply: The EU Commission’s Critical Medicines Act proposal

Court ruling: Delivery of cosmetic products that do not comply with labelling requirements constitutes an unfair marketing practice

The Green Claims Directive – New rules regarding environmental claims

Setterwalls Gold ranked by the World Trademark Review

Preliminary ruling from the European Court of Justice on plant-based “steak” and “sausage”

The EU Health Technology Assessment Regulation will soon apply

Updates in the ICC Advertising and Marketing Communications Code

An updated Swedish national strategy for life sciences

Labelling sausages “riktig korv” (eng. real sausage) was misleading

Switch and substitution of biological medicinal products in pharmacies

Overview of recent developments regarding the distinction between marketing and non-commercial information in relation to medicinal products

ICLG Drug and Medical Device Litigation Guide 2024: Setterwalls’ specialists explain the regulatory framework for the life sciences industry

EU Regulation for Non-Agri Geographical Indications Now in Force

New timeline for EUDAMED

First administrative fine based on the UTP Directive now imposed in Sweden

ICLG – Drug and Medical Device Litigation 2023: Setterwalls’ specialists explain the regulatory framework for the life sciences industry

Clarifications on the marketing of electronic cigarettes and refill containers

TLV reviews the price cap system

The legal framework for food contact materials

Use of nutrition and health claims in trademarks and brand names

The new regulation on in vitro diagnostic medical devices becomes applicable

Setterwalls’ specialists explain the regulatory framework for life sciences products and services in the ICLG: Drug and Medical Device Litigation 2022

The Patent and Market Court of Appeal rejects the Image Rule of the Alcohol Act – a high-profile case about moderation and proportionality

Marketing restrictions, age requirements and health warnings? – Proposed new regulations for tobacco-free nicotine products

Changed rules on the Swedish Keyhole label – Can ready meals be healthy?

Medical Devices Regulation– the day is finally here

Setterwalls' specialists explain the regulatory framework for life sciences products and services in the ICLG: Drug and Medical Device Litigation 2021

Nutrition and health claims in trademarks and product names – the transitional rule expires

LIF Calls for Review of Parallel-import Clauses in Side Agreements

Is your Business Prepared for the Implications of Brexit?

Brexit happened – what will occur to your EU IP rights?

Registering trademarks for medical devices

Postponement of the Medical Devices Regulation due to COVID-19

Brexit – a never-ending story?

Pricing and financing of pharmaceuticals

Collaborative model for introduction of medtech

Can you show use of your trademarks?

Sweden’s new national life sciences strategy: addressing major challenges

Insurance coverage when medications are prescribed off-label

Inquiry into the protection of research results in Sweden

New Measures to Help Food Companies Achieve Compliancy

Opinion from the Advocate General regarding classification of software as medical devices

New rules regarding labelling of alcoholic beverages may be on the way

Two new regulations for medical devices